Brown & Brown continues to attract value investors following a recent pullback in its share price, as the company’s track record of consistent profitability and disciplined capital allocation presents an appealing entry point. Analysts maintain a Buy recommendation based on Brown & Brown’s status as a compounder that has delivered double-digit adjusted EPS growth over the past five years. Management’s projection of free cash flow per share of $2.08 in 2025 underscores the firm’s ability to generate cash at scale, supporting both organic investment and accretive acquisitions.

In the quarter ended December 31, 2025, Brown & Brown reported total revenues of $1.6 billion, up 35.7% year-over-year, driven primarily by the Accession acquisition. Organic revenues declined 2.8%, reflecting timing variances in client renewals. Adjusted EBITDAC rose 35.6% to $529 million, while adjusted margin held steady at 32.9%. For the full year, total revenues reached $5.9 billion, up 22.8% versus 2024, with organic growth of 2.8%. Adjusted diluted earnings per share advanced 10.9% to $4.26, and adjusted EBITDAC margin expanded to 35.9%. These results highlight the company’s ability to balance acquisition-driven growth with margin discipline.

Management attributes the modest organic revenue decline in Q4 to two non-recurring items: timing shifts in profit-sharing contingent commissions and declines in catastrophe reinsurance rate levels. While commission and fee income on core business contracted by approximately 2.8%, executives stress that rate resets on large commercial portfolios and elevated reinsurance rates in specialty lines will support recovery in the first half of 2026. The firm’s guidance assumes normalization of these factors, indicating a resumption of mid-single-digit organic growth by midyear.

Brown & Brown’s well-stocked acquisition pipeline remains a cornerstone of its growth strategy, with over 70 active targets spanning retail brokerage, specialty programs and wholesale distribution. The company expects to deploy $1.2 billion in acquisition capital in 2026, financed through a combination of operating cash flow and committed credit facilities. As scale increases, management forecasts free cash flow conversion exceeding 80% of net income, enabling continued share repurchases and dividend increases without compromising balance sheet flexibility.